The purpose of this study was to compare the health-related quality of life (HRQOL) of Chinese patients with prostate cancer against the general population and patients with colorectal cancer, breast cancer, nasopharyngeal cancer, and leukemia.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
Chinese male patients (n = 291) with a confirmed diagnosis of prostate cancer were recruited from a urological specialist outpatient clinic in Hong Kong. HRQOL was measured by a condition-specific Functional Assessment of Cancer Therapy-Prostate (FACT-P) and a generic Chinese (HK) SF-12 Health Survey Version 2 (SF-12v2) questionnaire. Mean HRQOL scores of condition-specific and generic questionnaires were compared to available scores derived from other cancers and age-matched male general population, respectively.
Chinese patients with prostate cancer had lower general health and vitality domains and lower mental component summary scores than the age-matched Hong Kong normative population. Patients with prostate cancer reported better condition-specific HRQOL (physical well-being, emotional well-being and function well-being) when compared to general cancer population, patients with breast cancer, colorectal cancer, nasopharyngeal cancer, and leukemia in Hong Kong.
Patients with prostate cancer substantially perceived their HRQOL to be better, compared to patients with other cancers, with overall health, energy, and mental health below of Hong Kong general population. Interventions should target at these domains in order to improve the HRQOL of patients with prostate cancer. It is reassuring to find that prostate cancer had less negative impact on HRQOL than other cancer types did.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2015 Oct 09 [Epub ahead of print]
Edmond P H Choi, Carlos K H Wong, James H L Tsu, W Y Chin, Kenny Kung, Charles K W Wong, M K Yiu
School of Nursing, The University of Hong Kong, 4/F, William M. W. Mong Block, 21 Sassoon Road, Pokfulam, Hong Kong. Department of Family Medicine and Primary Care, The University of Hong Kong, Ap Lei Chau, Hong Kong. , Division of Urology, Department of Surgery, The University of Hong Kong, Pokfulam, Hong Kong. , Department of Family Medicine and Primary Care, The University of Hong Kong, Ap Lei Chau, Hong Kong. , Department of Family Medicine and Primary Care, The University of Hong Kong, Ap Lei Chau, Hong Kong. , Division of Urology, Department of Surgery, The University of Hong Kong, Pokfulam, Hong Kong. , Division of Urology, Department of Surgery, The University of Hong Kong, Pokfulam, Hong Kong.